Abstract 5997: Patient-derived cell line and organoid drug screening identifies synergistic PLK1 inhibitor in combination with senolytic ABT-263 for pancreatic cancer
Year: 2025
Type: conference-abstract
Source: Cancer Research
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409629453
